• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Krebs Biochemicals & Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3697.0
  • ISIN : INE268B01013
56.42 -1 (-2.01%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    55.20

  • Today’s High

    58.75

  • Open

    58.75

  • Perv Close

    57.58

  • 52W Low

    38.33

  • 52W High

    76.85

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    121.64

  • Div & Yield %

    0.00

  • Book Value(₹)

    -75.49

  • Debt-Equity Ratio

    -2.01

  • AGM Date

    29-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    121.64

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.56

  • BV (₹)

    -75.50

  • Sales( ₹ in Cr.)

    23.73

  • NP (in Cr.)

    -16.93

  • NP Var(%)

    37.0

  • Div%

    0.0

  • CPS (₹)

    -4.90

  • EPS (₹)

    -7.90

  • Traded Value (₹ in Lakhs)

    127.23

  • 52 Week High

    76.85

  • 52 Week Low

    38.33

  • Price BSE

    59.0

  • Price NSE

    56.00

  • Market Capital( in Cr.)

    127.23

  • P/C Ratio

    -12.10

  • P/E Ratio

    -7.50

  • Price Vs.BV

    -7.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 23.73 43.31 50.42 52.13 59.70 53.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 23.73 43.31 50.42 52.13 59.70 53.70
Other Income 2.03 0.71 0.45 0.62 1.16 0.62
Stock Adjustments -0.34 -3.03 -1.07 -5.87 5.54 -0.32
Total Income 25.42 40.99 49.80 46.88 66.40 54.00
EXPENDITURE :            
Raw Materials 0.05 2.53 5.52 19.81 46.18 25.62
Power and Fuel Cost 9.61 18.52 22.01 14.80 22.23 15.91
Employee Cost 10.09 16.30 16.17 15.54 14.96 15.30
Other Manufacturing Expenses 2.89 12.59 9.75 7.17 9.64 10.48
Selling and Administration Expenses 4.04 5.24 4.50 4.57 6.11 3.39
Miscellaneous Expenses 2.17 0.13 0.11 0.17 0.11 0.24
Employee Benefit Expenses 10.09 16.30 16.17 15.54 14.96 15.30
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 28.84 55.32 58.08 62.05 99.24 70.95
Operating Profit -3.42 -14.32 -8.27 -15.16 -32.84 -16.95
Interest 7.09 5.91 4.69 2.97 5.39 6.28
Gross Profit -10.51 -20.23 -12.96 -18.13 -38.23 -23.23
Depreciation 6.42 6.69 6.77 6.56 6.30 5.12
Profit Before Tax -16.93 -26.92 -19.73 -24.69 -44.53 -28.35
Current Tax 0.00 0.02 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -16.93 -26.94 -19.73 -24.69 -44.53 -28.36
Extraordinary Items 0.00 0.12 0.00 0.00 0.00 0.00
Adjusted Net Profit -16.93 -27.06 -19.73 -24.69 -44.53 -28.36
Adjustment below Net Profit 0.42 -0.08 -0.03 0.32 -0.35 0.17
P & L Balance brought forward -297.26 -270.24 -250.49 -226.12 -181.24 -153.06
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -313.78 -297.26 -270.24 -250.49 -226.12 -181.24
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -7.85 -12.49 -9.15 -11.45 -20.65 -14.45
Earnings Per Share(Adj)-Unit Curr -7.85 -12.49 -9.15 -11.45 -20.65 -14.45
Book Value -75.49 -67.83 -55.29 -46.13 -34.83 -23.91
Book Value(Adj)-Unit Curr -75.49 -67.83 -55.29 -46.13 -34.83 -23.91

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,705,195 49.65 10,705,195 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,978,939 23.09 4,958,539 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,684,134 72.74 15,663,734 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 1,822 0.01 522 4
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 105,000 0.49 105,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 106,822 0.50 105,522 5
2] Non Institution
Bodies Corporate 1,092,611 5.07 1,089,010 72
Clearing Members 0 0.00 0 0
Directors of their Relatives 7,837 0.04 7,837 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 279,778 1.30 279,778 102
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 149,484 0.69 149,484 193
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,971,605 9.14 1,761,605 25
Individuals holding nominal share capital up to Rs. 1 lakh 2,268,313 10.52 2,151,783 8,114
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 2
Sub Total 5,769,630 26.76 5,439,499 8,510
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,560,586 100.00 21,208,755 8,521

Company Background

Krebs Biochemicals & Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Krebs Biochemicals & Industries Ltd
  • BSE Code : 3697.0
  • ISIN : INE268B01013

  • Incorporation Year

    1991

  • Registered Office

    Kothapalli(V) Kasimkota(M)
    Anakapalli, Vishakapatnam,
    Andhra Pradesh-531031

  • Telephone

    91-040-6680 8040

  • FAX

  • Chairman

    R T Ravi

  • Managing Director

    Manish Kumar Jain

  • Company Secretary

    Rakesh R Kalbate

  • Auditor

    Bhavani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Krebs Biochemicals & Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Krebs Biochem 59.01 25.76 23.73 -9.02 0.00
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77